Arcus Biosciences Inc (RCUS)

Deferred Revenue

$19.00M

Quarterly · Period ending: · USD

RCUS logo

RCUS Deferred Revenue

Latest reported$19.00M
RCUS Quarterly Deferred Revenue ($0.00 → $19.00M)
High-resolution chart · PNG

RCUS deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arcus Biosciences Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
19,000,000
34,000,000
35,000,000
52,000,000
71,000,000
72,000,000
85,000,000
105,000,000
113,000,000
124,000,000
91,000,000
103,000,000
103,000,000
97,000,000
97,000,000
103,291,000
90,117,000
89,310,000
102,003,000
74,343,000
74,571,000
74,571,000
74,571,000
117,514,000
7,000,000
7,000,000
7,000,000
7,000,000
7,000,000
7,000,000
6,250,000
6,250,000
5,000,000
5,000,000
5,000,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.